FDA Reviews Rules Keeping Cigarettes from Kids and Teens
Published Date: 8/22/2025
Notice
Summary
The FDA wants your thoughts on how they collect info about rules that stop kids and teens from buying cigarettes and smokeless tobacco. This affects stores and sellers who must follow these rules to keep tobacco away from young people. They’re asking for comments over the next 60 days to make sure the process is clear and fair, with no extra costs or hassles.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
Stores Must Provide Tobacco Info
The FDA is asking for public comment for 60 days on its information collection tied to regulations that restrict the sale and distribution of cigarettes and smokeless tobacco to protect children and adolescents. This affects stores and sellers who must follow those rules and may need to provide information to the Agency about their compliance.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12855 — Sterigenics U.S., LLC; Filing of Food Additive Petition
Sterigenics U.S., LLC wants to get approval to use a new food additive. This affects food makers and consumers by potentially changing how certain foods are treated or preserved. No big costs or deadlines are mentioned yet, but keep an eye out for updates as the process moves forward!
2026-12621 — Expedited Investigational New Drug Pilot Program; Request for Information
The FDA wants to speed up how fast new drugs get tested on people by creating a special pilot program. This program will team up trusted research groups with drug makers to review early study plans faster, while keeping safety top priority. If you’re involved in drug research or healthcare, now’s your chance to share ideas before July 22, 2026!
2026-12679 — International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Bovines; Guidance for Industry; Availability
The FDA just released new guidance to help companies test worm-killing medicines for cows. This makes it easier for drug makers worldwide to prove their products work, speeding up approvals and keeping cattle healthy. Farmers, vets, and drug companies should watch for these changes starting now—no extra costs, just clearer rules!
2026-12622 — Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products; Revised Draft Guidance for Industry; Availability
The FDA just released a new draft guide to help drug makers prove their medicines really work, using smarter and faster science. This update affects companies developing human drugs and biological products, aiming to save time and money by allowing strong evidence from just one good clinical study plus extra proof. Comments on this draft are open until September 22, 2026, so industry folks have a chance to weigh in before it becomes final.
2026-12681 — International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Caprines; Guidance for Industry; Availability
The FDA just released new guidance to help drug makers prove their worm-killing medicines work well in goats. This makes it easier for companies worldwide to get their products approved by following the same rules. Goat farmers, vets, and drug companies should watch for these updates starting June 24, 2026, which could speed up getting effective treatments to animals without extra costs.
2026-12620 — Master Protocols for Drug and Biological Product Development; Draft Guidance for Industry; Availability
The FDA just dropped a fresh draft guidance to help drug and biological product makers run smarter, faster clinical trials using master protocols. This update affects companies developing new medicines by clarifying how to design and submit these trials for approval. If you’re in the game, get your comments in by August 24, 2026, or risk missing out on shaping the final rules—and maybe saving time and money down the road!
Previous / Next Documents
Previous: 2025-16066 — Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational Device Exemptions Reports and Records
The FDA wants your thoughts on how it collects info about testing new medical devices before they hit the market. This affects companies and researchers who test these devices, and the FDA is asking for feedback over the next 60 days to keep things clear and efficient. No big money changes yet, just a chance to help shape the rules!
Next: 2025-16068 — Agency Information Collection Activities; Proposed Collection; Comment Request; Tobacco Retailer Training Programs
The FDA wants your thoughts on how tobacco stores train their workers to follow the rules. This helps make sure tobacco is sold safely and legally, especially to keep it away from kids. If you run or work at a tobacco shop, or just care about safe sales, now’s the time to speak up before the 60-day comment period ends!